ACADIA Pharmaceuticals Inc. (ACAD) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $4.55B, a trailing price-to-earnings ratio of 34.8 and a free-cash-flow yield of 2.4%. Over the most recent reported fiscal year, revenue grew 11.9% and free cash flow per share fell 34.5%.